Reliability of Sensor Spacing for NIRS in Traumatic Tibia Fractures
1 other identifier
observational
14
1 country
1
Brief Summary
This is a study intended to evaluate a non-invasive device that uses light to measure the amount of oxygen in the muscles of injured and non-injured legs in specific situations. The name of this technology is NIRS (near-infrared spectroscopy). The goal of this study is to collect the information necessary to understand the use of the NIRS monitoring system to diagnose and direct treatment decisions in case of complications sometimes experienced in traumatic tibia fracture, such as excessive swelling called acute compartment syndrome (ACS).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 24, 2014
CompletedFirst Posted
Study publicly available on registry
November 26, 2014
CompletedStudy Start
First participant enrolled
December 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 20, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
July 20, 2016
CompletedFebruary 6, 2017
February 1, 2017
1.6 years
November 24, 2014
February 3, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
NIRS measurements as compared to clinical findings
Assess the accuracy of the Nonin 7600 oximeter with the Sensor Model 8004CV in the diagnosis of Acute Compartment Syndrome, using the "gold standard" criterion for ACS, which will be "clinical diagnosis". That is, all subjects undergoing fasciotomy for clinically diagnosed ACS will be considered to have ACS. NIRS values will be compared to clinical diagnosis to determine accuracy and threshold values.
Participants will be followed for the duration of hospital stay, an expected average of 72 hours
Secondary Outcomes (2)
Accuracy of NIRS measurements compared to Intracompartmental pressure (ICP) measurements
Participants will be followed for the duration of hospital stay, an expected average of 72 hours
Correlation between NIRS measurements between injured and uninjured extremity
Participants will be followed for the duration of hospital stay, an expected average of 72 hours
Eligibility Criteria
Subjects will be recruited from the trauma bay, surgical wards and ICU of Grady Memorial Hospital.
You may qualify if:
- Unilateral leg injury
- Enrolled within 48 hours of injury
- Subjects with 'severe' leg injuries presenting at trauma center that meet at least one of the following from each group below:
- Anatomic location:
- Tibia/Fibula shaft fracture
- Tibial plateau fracture (Schatzker III-VI)
- High Energy Mechanism of Injury:
- Fall from \>8 foot height
- Motor vehicle collision (\> 15 mph)
- Motor vehicle versus pedestrian accident
- High velocity gunshot wound
- Crush injury
- Sport/recreation
You may not qualify if:
- Application of NIRS monitoring would be an impediment to care
- Known prior leg fractures, patient has already undergone fasciotomy of the injured leg prior to enrollment
- History of peripheral vascular disease or concurrent lower extremity vascular injury/surgery
- Admission for atraumatic medical reasons
- Subject is unable to provide informed consent, or consent cannot be obtained from a legally authorized representative
- Complete spinal cord injuries, bilateral upper extremity injuries, or amputation/mangled lower extremity
- Patients who are in police custody at presentation to the hospital or who are pregnant
- Patient has an open injury on the injured leg that is large enough that at least one NIRS sensor cannot be safely placed over the compartment
- Bilateral leg injuries
- Not able to be enrolled within 48 hours after injury
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Emory Universitylead
Study Sites (1)
Grady Memorial Hospital
Atlanta, Georgia, 30303, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
William Reisman, MD
Emory University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- William Reisman MD
Study Record Dates
First Submitted
November 24, 2014
First Posted
November 26, 2014
Study Start
December 1, 2014
Primary Completion
July 20, 2016
Study Completion
July 20, 2016
Last Updated
February 6, 2017
Record last verified: 2017-02